Comparison of the long-term results of brachytherapy for T1-2N0 oral tongue cancer treated with Ir-192 and Ra-226

Anticancer Res. 1997 Jul-Aug;17(4A):2819-22.

Abstract

Background: The authors report the compatibility of iridium-192 (Ir-192) to Radium-226 (Ra-226) based on the clinical results of three-decades.

Methods: From 1967 through 1985, 119 patients with early oral tongue cancer (T1-2N0) were treated with conventional Ra-226 needles and 135 patients with Ir-192 hair pins.

Results: Local control rates at 10 years for T1 and T2 tongue cancer were 79% and 61% for patients treated with Ra-226, 83% and 68% with Ir-192. The 10-year cause-specific survival rates for the T1 and T2 patients with Ra-226 were 76% and 63%, and those with Ir-192 were 77% and 68%, respectively.

Conclusions: Ir-192 showed good possibilities as a substitute for Ra-226 in brachytherapy for early oral tongue cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Brachytherapy
  • Carcinoma, Squamous Cell / radiotherapy*
  • Female
  • Humans
  • Iridium Radioisotopes / therapeutic use*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Radium / therapeutic use*
  • Survival Analysis
  • Tongue Neoplasms / radiotherapy*

Substances

  • Iridium Radioisotopes
  • Radium